ID
39972
Descripción
Study ID: 110852 Clinical Study ID: 110852 Study Title: MD7110852, A Phase 2b Dose-Ranging Study of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01134055 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: pazopanib eye drops, ranibizumab intravitreal injection, placebo Trade Name: pazopanib, ranibizumab Study Indication: Macular Degeneration
Palabras clave
Versiones (1)
- 6/3/20 6/3/20 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
6 de marzo de 2020
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration NCT01134055
Week 28 - Eye Drop Administration; Treatment Preference Questionnaire
Descripción
Eye Drop Administration
Alias
- UMLS CUI-1
- C0015399
- UMLS CUI-2
- C1533734
Descripción
Who has been primarily responsible for administering the medication (eye drops) over the study?
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0015399
- UMLS CUI [1,2]
- C1533734
- UMLS CUI [1,3]
- C0678341
- UMLS CUI [1,4]
- C0008976
- UMLS CUI [1,5]
- C0347984
Descripción
If other person is responsible for administering the medication, specify
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0015399
- UMLS CUI [1,2]
- C1533734
- UMLS CUI [1,3]
- C0678341
- UMLS CUI [1,4]
- C0205394
- UMLS CUI [1,5]
- C2348235
Similar models
Week 28 - Eye Drop Administration; Treatment Preference Questionnaire
C0558295 (UMLS CUI-2)
C0034394 (UMLS CUI-3)
C1272700 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0558295 (UMLS CUI [3])
C1331418 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0030193 (UMLS CUI [3])
C2364135 (UMLS CUI [4])
C1706307 (UMLS CUI [5])
C4061283 (UMLS CUI [6])
C0087111 (UMLS CUI [7,1])
C0558295 (UMLS CUI [7,2])
C1527305 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0004083 (UMLS CUI [2,3])
C0027769 (UMLS CUI [3])
C4054984 (UMLS CUI [4])
C0003467 (UMLS CUI [5])
C0700361 (UMLS CUI [6])
C0087111 (UMLS CUI [7,1])
C0558295 (UMLS CUI [7,2])
C4049986 (UMLS CUI [2])
C0871707 (UMLS CUI [3])
C0087111 (UMLS CUI [4,1])
C0558295 (UMLS CUI [4,2])
C0087111 (UMLS CUI [2,1])
C1707391 (UMLS CUI [2,2])
C0392360 (UMLS CUI [2,1])
C1707391 (UMLS CUI [2,2])
C1533734 (UMLS CUI-2)
C1533734 (UMLS CUI [1,2])
C0678341 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,4])
C0347984 (UMLS CUI [1,5])
C1533734 (UMLS CUI [1,2])
C0678341 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])